| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1478951504040234 |
| P698 | PubMed publication ID | 16594247 |
| P2093 | author name string | Christopher Gibson | |
| William Breitbart | |||
| Daniele Stagno | |||
| P2860 | cites work | Prevalence of psychotic symptoms in delirium | Q30306534 |
| EEG spectral analysis in delirium | Q33628041 | ||
| Epidemiology of delirium | Q33726591 | ||
| Update on the neuropathogenesis of delirium | Q33726603 | ||
| Clinical subtypes of delirium in the elderly | Q33726646 | ||
| Delirium in the terminally ill. | Q33900229 | ||
| Palliative uses of methylphenidate in patients with cancer: a review. | Q33956684 | ||
| A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients | Q34371532 | ||
| The course of delirium in older medical inpatients: a prospective study | Q34742312 | ||
| The role of right hemisphere dysfunction in psychiatric disorders | Q36138638 | ||
| CNS Arousal Systems: Possible Role in Delirium | Q36549683 | ||
| Delirium in the elderly patient | Q38601576 | ||
| Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? | Q39466326 | ||
| Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer | Q40513847 | ||
| Delirium in AIDS patients: recognition and medication factors | Q40602687 | ||
| The neuropathogenesis of delirium. A need to focus our research | Q40625700 | ||
| The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients | Q40707119 | ||
| The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy | Q41012755 | ||
| Acute confusional states in patients with advanced cancer | Q43475844 | ||
| An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients | Q44035356 | ||
| Delirium severity and psychomotor types: their relationship with outcomes after hip fracture repair | Q44329049 | ||
| Quantitative EEG analysis and survival in liver disease | Q44515104 | ||
| Unsuspected emotional and cognitive disturbance in medical patients | Q45063856 | ||
| Cerebral blood flow during delirium tremens and related clinical states studied with xenon-133 inhalation tomography | Q45769881 | ||
| Agitated delirium caused by infarctions of the hippocampal formation and fusiform and lingual gyri: a case report | Q48500058 | ||
| Delirium in dementia | Q48518421 | ||
| Transient cognitive disorders (delirium, acute confusional states) in the elderly | Q48719247 | ||
| Relationship between symptoms and motoric subtype of delirium | Q48729972 | ||
| A multicomponent intervention to prevent delirium in hospitalized older patients | Q48770791 | ||
| Relationship between etiology and phenomenologic profile in delirium | Q48773412 | ||
| An empirical study of delirium subtypes | Q48880664 | ||
| Delirium (acute confusional states). | Q48970536 | ||
| The use of propofol in palliative medicine. | Q51590284 | ||
| Propofol in terminal care. | Q51590288 | ||
| Subcutaneous midazolam infusion in palliative care. | Q51729013 | ||
| The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. | Q51956014 | ||
| Acute confusional states and dementia in the elderly: the role of dehydration/volume depletion, physical illness and age. | Q52103953 | ||
| Palliative Uses of Methylphenidate in Patients With Cancer: A Review | Q56158488 | ||
| Phenomenology of acute confusional states | Q59388116 | ||
| Etiologic and Outcome Profiles in Hypoactive and Hyperactive Subtypes of Delirium | Q59388124 | ||
| Les syndromes confusionnels du sujet âgé hospitalisé: polymorphisme sémiologique et évolutif. Étude prospective de 183 patients | Q59388134 | ||
| A Retrospective Study on Delirium Type | Q67835218 | ||
| Midazolam in terminal care | Q69910887 | ||
| The use of environmental strategies and psychotropic medication in the management of delirium | Q71324216 | ||
| Usage of haloperidol for delirium in cancer patients | Q71709787 | ||
| Delirium in terminally ill cancer patients | Q71783632 | ||
| Adverse consequences of hospitalization in the elderly | Q72047809 | ||
| Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate | Q73597743 | ||
| Delirium, a syndrome of cerebral insufficiency | Q78557096 | ||
| P433 | issue | 2 | |
| P921 | main subject | delirium | Q160796 |
| pathophysiology | Q1135939 | ||
| P304 | page(s) | 171-179 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Palliative and Supportive Care | Q15758536 |
| P1476 | title | The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response | |
| P478 | volume | 2 |
| Q38049733 | Assessment and management of delirium: a focus on hepatic encephalopathy |
| Q83819150 | Characteristics, interventions, and outcomes of misdiagnosed delirium in cancer patients |
| Q36728558 | Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice |
| Q90043056 | Clinical management of delirium: The response depends on the subtypes. An observational cohort study in 602 patients |
| Q37435834 | Comprehensive approaches to managing delirium in patients with advanced cancer |
| Q30300407 | Comprehensive care in gynecologic oncology: The importance of palliative care |
| Q40848472 | Delirium Frequency and Risk Factors Among Patients With Cancer in Palliative Care Unit |
| Q38911213 | Delirium and Mortality in Critically Ill Children: Epidemiology and Outcomes of Pediatric Delirium |
| Q41098975 | Delirium as letting go: An ethnographic analysis of hospice care and family moral experience |
| Q84040887 | Delirium in patients with head and neck cancer in the outpatient treatment setting |
| Q90175327 | Delirium in the intensive care setting dependent on the Richmond Agitation and Sedation Scale (RASS): Inattention and visuo-spatial impairment as potential screening domains |
| Q91979951 | Delirium is prevalent in older hospital inpatients and associated with adverse outcomes: results of a prospective multi-centre study on World Delirium Awareness Day |
| Q89180379 | Delirium's Arousal Subtypes and Their Relationship with 6-Month Functional Status and Cognition |
| Q36635373 | Delirium: the clinical concept |
| Q47592744 | Delirium: underrecognized and undertreated |
| Q37225941 | Delirium: where do we stand? |
| Q48548944 | EEG changes and serum anticholinergic activity measured in patients with delirium in the intensive care unit |
| Q36822176 | Evidence-based treatment of delirium in patients with cancer |
| Q39395738 | Exploring Delirium's Heterogeneity: Association Between Arousal Subtypes at Initial Presentation and 6-Month Mortality in Older Emergency Department Patients |
| Q90036812 | Impact of psychotic symptoms on clinical outcomes in delirium |
| Q39162240 | Incidence, risk factors, and phenomenological characteristics of postoperative delirium in patients receiving intravenous patient-controlled analgesia: a prospective cohort study |
| Q37204212 | Is cobalamin deficiency associated with increased risk of all subtypes of postoperative delirium? |
| Q35557971 | Management of delirium in palliative care: a review |
| Q92501868 | Mental health care in oncology. Contemporary perspective on the psychosocial burden of cancer and evidence-based interventions |
| Q34945773 | Motor subtypes of delirium: past, present and future |
| Q38182267 | Phenomenology of the subtypes of delirium: phenomenological differences between hyperactive and hypoactive delirium |
| Q26782925 | Recent Insights on Prevalence and Corelations of Hypoactive Delirium |
| Q58766619 | Risk factors and incidence of postoperative delirium in elderly patients after elective and emergency surgery |
| Q90286459 | Role of Wearable Accelerometer Devices in Delirium Studies: A Systematic Review |
| Q33754923 | Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center. |
| Q37696747 | Smoking Cessation and the Risk of Hyperactive Delirium in Hospitalized Patients: A Retrospective Study |
| Q56984928 | The Role of Intravenous Agents in Delirium |
| Q50600158 | The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center. |
| Q37716682 | The neuroinflammatory hypothesis of delirium |
| Q26747296 | Understanding cognition in older patients with cancer |
| Q38290683 | Use of aripiprazole for delirium in the elderly: a short review |
| Q87423697 | [Delirium on the ICU: clinical impact, diagnostic workup, and therapy] |
Search more.